UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, DC D.C. 20549

_______________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of ~~the~~ The

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): ~~July~~April 74, ~~2008~~2009

PERFORMANCE HEALTH TECHNOLOGIES, INC. ~~(Exact Name of Registrant as Specified in Charter)~~

Delaware	000-52647	841474432
(State or Other Jurisdiction of	(Commission	(IRS Employer
Incorporation)	File Number)	Identification No.)

(Exact name of registrant as specified in its charter)

Delaware	000-52647	841474432
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

427 Riverview Plaza, Trenton, NJ		08611
(Address of Principal Executive Offices)		(Zip Code)

Our telephone number, including area code: (609) 656-0800

Not Applicable (Former ~~Name~~name or ~~Former~~former ~~Address~~address, if ~~Changed~~changed ~~Since~~since ~~Last~~last ~~Report~~report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of us under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~Section 5—Corporate ~~7.01~~Governance ~~Regulation~~and ~~FD Disclosure.~~Management

OnItem ~~July 7, 2008, Performance Health Technologies, Inc~~5.02 ~~(the~~Departure ~~“Company”)~~of isDirectors ~~giving~~or ~~two presentations~~Certain inOfficers; ~~connection~~Election ~~with~~of ~~the~~Directors; ~~Company~~Appointment inof ~~New~~Certain ~~York~~Officers; ~~City. The presentation~~Compensatory ~~material,~~Arrangements ~~which~~of ~~discusses~~Certain ~~the Company’s present business operations, plans and strategy, is attached hereto as Exhibit 99~~Officers.~~1. This Current Report and Exhibit 99.1 hereto are being furnished pursuant to Regulation FD.~~

~~This information~~(b) ~~is furnished pursuant to Item 7.01 of Form 8-K and shall not be~~On ~~deemed~~April ~~to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934~~4, ~~as amended~~2009, orDavid ~~otherwise~~J. ~~subject~~Lenihan toresigned ~~liability~~as ~~under~~a ~~that~~Director ~~section, nor~~of ~~shall~~Performance ~~it be deemed incorporated by reference into any filing under the~~Health ~~Securities Act of 1933~~Technologies, ~~as amended, except as shall be expressly set forth by specific reference in such filing~~Inc. By ~~filing this report on Form 8-K and furnishing this information,~~ (the “Company ~~makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD~~”).

Item 9.01. Financial Statements and Exhibits.

99.1 Presentation of Performance Health Technologies, Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this report to be signed on our behalf by the undersigned hereunto duly authorized.

Date: July 7, 2008	PERFORMANCE HEALTH TECHNOLOGIES, INC.
	(Registrant)
	By:	/s/ Robert D. Prunetti
		Robert D. Prunetti
		Chief Executive Officer

Date: April 7, 2009

	PERFORMANCE HEALTH TECHNOLOGIES, INC. (Registrant)

	By:	/s/ Robert D. Prunetti
		Robert D. Prunetti
		Chief Executive Officer

Filing Compare · PERFORMANCE HEALTH TECHNOLOGIES INC